Organ Preservation for Muscle-Invasive Bladder Cancer by Transurethral Resection

Urology

Volumn 70, Issue 3, 2007, Pages 473-476

  Leibovici, Dan ^a   Kassouf, Wassim ^a   Pisters, Louis L ^a   Pettaway, Curtis A ^a   Wu, Xifeng ^a   Dinney, Colin P ^a   Grossman, H Barton ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; MITOMYCIN C;

ADJUVANT THERAPY; AGED; ARTICLE; BLADDER CANCER; BLADDER MUSCLE; CANCER CHEMOTHERAPY; CANCER INVASION; CANCER MORTALITY; CANCER RECURRENCE; CANCER SIZE; CONTROLLED STUDY; CYSTECTOMY; CYSTOSCOPY; DISEASE FREE SURVIVAL; FOLLOW UP; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; METASTASIS; ORGAN PRESERVATION; OVERALL SURVIVAL; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURGICAL RISK; SURVIVAL RATE; TRANSURETHRAL RESECTION;

AGED; ANTINEOPLASTIC AGENTS; BCG VACCINE; CARCINOMA, TRANSITIONAL CELL; COMBINED MODALITY THERAPY; CYSTECTOMY; DISEASE-FREE SURVIVAL; FEASIBILITY STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; MUSCLE, SMOOTH; NEOPLASM INVASIVENESS; PATIENT SELECTION; RETROSPECTIVE STUDIES; SURVIVAL RATE; URINARY BLADDER NEOPLASMS;

EID: 34648843748     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2007.05.007     Document Type: Article

References (20)

1. Cervek J., Cufer T., Zakotnik B., et al. Invasive bladder cancer: our experience with bladder sparing approach. Int J Radiat Oncol Biol Phys 41 (1998) 273-278
2. Rodel C., Grabenbauer G.G., Kuhn R., et al. Combined-modality treatment and selective organ preservation in invasive bladder cancer: long-term results. J Clin Oncol 20 (2002) 3061-3071
3. Herr H.W. Transurethral resection of muscle-invasive bladder cancer: 10-year outcome. J Clin Oncol 19 (2001) 89-93
4. Thrasher J.B., Frazier H.A., Robertson J.E., et al. Does of stage pT0 cystectomy specimen confer a survival advantage in patients with minimally invasive bladder cancer?. J Urol 152 (1994) 393-396
5. Shipley W.U., Kaufman D.S., Zehr E., et al. Selective bladder preservation by combined modality protocol treatment: long-term outcomes of 190 patients with invasive bladder cancer. Urology 60 (2002) 62-67
6. Dunst J., Rodel C., Zietman A., et al. Bladder preservation in muscle-invasive bladder cancer by conservative surgery and radiochemotherapy. Semin Surg Oncol 20 (2001) 24-32
7. Zietman A.L., Grocela J., Zehr E., et al. Selective bladder conservation using transurethral resection, chemotherapy, and radiation: management and consequences of Ta, T1, and Tis recurrence within the retained bladder. Urology 58 (2001) 380-385
8. Solsona E., Iborra I., Ricos J.V., et al. Feasibility of transurethral resection for muscle infiltrating carcinoma of the bladder: long-term followup of a prospective study. J Urol 159 (1998) 95-98
9. Roosen J.U., Geertsen U., Jahn H., et al. Invasive, high grade transitional cell carcinoma of the bladder treated with transurethral resection: a survival analysis focusing on TUR as monotherapy. Scand J Urol Nephrol 31 (1997) 39-42
10. Bayraktar Z., Gurbuz G., Tasci A.I., et al. Staging error in the bladder tumor: the correlation between stage of TUR and cystectomy. Int Urol Nephrol 33 (2001) 627-629
11. Raghavan D., Shipley W.U., Garnick M.B., et al. Biology and management of bladder cancer. N Engl J Med 322 (1990) 1129-1138
12. Grossman H.B., Natale R.B., Tangen C.M., et al. Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. N Engl J Med 349 (2003) 859-866
13. Miladi M., Peyromaure M., Zerbib M., et al. The value of a second transurethral resection in evaluating patients with bladder tumours. Eur Urol 43 (2003) 241-245
14. Herr H.W. The value of a second transurethral resection in evaluating patients with bladder tumors. J Urol 162 (1999) 74-76
15. Stackl W., Baierlein M., and Albrecht W. Bladder preservation in muscle-invasive bladder cancer. Br J Urol 82 (1998) 357-360
16. Kuczyk M., Turkeri L., Hammerer P., et al. Is there a role for bladder preserving strategies in the treatment of muscle-invasive bladder cancer?. Eur Urol 44 (2003) 57-64
17. Zapatero A., deVidales C.M., Marin A., et al. Invasive bladder cancer: a single-institution experience with bladder-sparing approach. Int J Cancer 90 (2000) 287-294
18. Zietman A.L., Sacco D., Skowronski U., et al. Organ conservation in invasive bladder cancer by transurethral resection, chemotherapy and radiation: results of a urodynamic and quality of life study on long-term survivors. J Urol 170 (2003) 1772-1776
19. Herr H.W., Bajorin D.F., Scher H.I., et al. Can p53 help select patients with invasive bladder cancer for bladder preservation?. J Urol 161 (1999) 20-22
20. Pieras E., Palou J., Salvador J., et al. Management and prognosis of transitional cell carcinoma superficial recurrence in muscle-invasive bladder cancer after bladder preservation. Eur Urol 44 (2003) 222-225